Health

Healthcare Policy: Myeloma UK's Call for Equitable NHS Access to CAR-T Cell Treatment

Myeloma UK is campaigning to ensure life-changing CAR-T cell therapy is accessible to all myeloma patients, regardless of their ability to pay.

Dopamine as an Addiction?

Can you be addicted to dopamine? The short answer is no. However, despite this common misconception, dopamine does play a key role in addiction behavioural patterns.

A Millennia-Old Mutation with Modern Implications

A genetic mutation known as CCR5Δ32, originating between 6,700 and 9,000 years ago near the Black Sea, provided ancient humans with a controlled immune response to emerging pathogens and now plays a crucial role in modern HIV resistance and gene-editing therapies.

Kandu Health and Neurolutions Merge to Transform Stroke Recovery

Kandu, Inc. merges Kandu Health and Neurolutions to create an innovative, integrated approach to stroke recovery, combining advanced technology with personalized, at-home care.

The Current and Future State of Personalised Medicine

How precision treatments, AI, and genomics are reshaping healthcare by using advanced technologies to deliver tailored treatments, early diagnoses, and better patient outcomes.

Alys Pharmaceuticals Begins Phase IIa Trial for ALY-101 in Alopecia Areata

The pioneering immuno-dermatology company has announced the successful dosing of the first patient in its Phase IIa clinical trial for ALY-101, a novel treatment for Alopecia Areata.